Clinical Trial Update: Adjunct Minocyline in Treatment-resistant Depression [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating adjunct minocycline for treatment-resistant major depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Minocycline (minocycline)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED